// MICROBIOLOGY Questions
// Auto-generated from questions.ts
// Total Questions: 13

import { Question } from '../types';

export const questions: Question[] = [
{
    id: "neet-pg-2023-1",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "L A patient hailing from Delhi presents with fever, arthralgia, and extensive petechial rash for 3 days. Lab investigations revealed a hemoglobin of 9 g/ dL, a white blood cell count of 9000 cells/mm3, a platelet coupnt of 20000 cells/mm3, and a prolonged bleeding time. The clotting time was normal. What is the most likely diagnosis?",
    options: [
      "Dengue e",
      "Malari r",
      "Scrub typhus P",
      "Typhoid",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Dengue (Option A)**\n\nüî¨ **DENGUE FEVER:**\n\n**ETIOLOGY:**\n‚Ä¢ **Dengue virus** (DENV 1-4) - **Flavivirus family** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Vector:** **Aedes aegypti** (day-biting mosquito) ‚≠ê\n‚Ä¢ **Endemic** in tropical/subtropical regions\n\n**CLINICAL PRESENTATION:**\n‚Ä¢ **Fever** (high, 39-40¬∞C, **biphasic** - saddle-back) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Arthralgia** (\"breakbone fever\") ‚≠ê\n‚Ä¢ **Petechial rash** (maculopapular, appears day 3-5) ‚≠ê\n‚Ä¢ **Headache, retro-orbital pain**\n‚Ä¢ **Muscle pain**\n\n**KEY LAB FINDINGS (THIS CASE):**\n\n**Thrombocytopenia:** **Platelet count <20,000/mm¬≥** ‚≠ê‚≠ê‚≠ê **(HALLMARK)**\n‚Ä¢ **Mechanism:** Bone marrow suppression + immune-mediated destruction\n‚Ä¢ **Critical:** <20,000 ‚Üí High bleeding risk\n\n**Prolonged Bleeding Time:** ‚≠ê (due to low platelets)\n‚Ä¢ **Normal clotting time** (coagulation cascade intact)\n\n**Hemoglobin:** 9 g/dL (anemia from bleeding)\n‚Ä¢ **Hemoconcentration** (‚ÜëHct >20%) suggests **severe dengue**\n\n**WBC:** 9000/mm¬≥ (normal/low)\n‚Ä¢ **Leukopenia** common (day 2-3)\n\n**DENGUE CLASSIFICATION (WHO 2009):**\n\n**Dengue without warning signs** (simple fever)\n\n**Dengue with warning signs** ‚≠ê:\n‚Ä¢ Abdominal pain\n‚Ä¢ Persistent vomiting\n‚Ä¢ Clinical fluid accumulation (ascites, pleural effusion)\n‚Ä¢ Mucosal bleed\n‚Ä¢ **Lethargy**, **restlessness**\n‚Ä¢ Hepatomegaly >2cm\n‚Ä¢ **Platelet <100,000** + **Rising Hct**\n\n**Severe Dengue** (formerly DHF/DSS):\n‚Ä¢ **Severe plasma leakage** (shock, fluid accumulation)\n‚Ä¢ **Severe bleeding** (GI bleed, menorrhagia)\n‚Ä¢ **Organ failure** (ALT/AST >1000, renal failure, CNS)\n\n**DIAGNOSIS:**\n‚Ä¢ **NS1 antigen** (day 1-7) ‚≠ê‚≠ê‚≠ê **(EARLY DIAGNOSIS)**\n‚Ä¢ **IgM antibody** (day 5 onwards)\n‚Ä¢ **RT-PCR** (confirmation)\n\n**MANAGEMENT:**\n‚Ä¢ **Supportive care** (hydration, paracetamol) ‚≠ê\n‚Ä¢ **Avoid NSAIDs/Aspirin** ‚≠ê‚≠ê‚≠ê (‚Üë bleeding risk)\n‚Ä¢ **Platelet transfusion** (if <10,000 or active bleeding)\n‚Ä¢ **Monitor Hct** (rising Hct = plasma leakage)\n\n**VS OTHER OPTIONS:**\n‚Ä¢ **Malaria:** Splenomegaly, normal platelets, peripheral smear positive\n‚Ä¢ **Scrub typhus:** Eschar, normal platelets\n‚Ä¢ **Typhoid:** Step-ladder fever, relative bradycardia, no rash\n\nüí° **KEY:** **Fever + Petechial rash + Thrombocytopenia (<50,000) = Dengue** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-2",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "Which of the following statements is true about Trichomonas vaginalis?",
    options: [
      "It cannot be cultured",
      "Twitching motility is seen on wet saline mount",
      "Cysts are seen on wet saline mount of vaginal secretions",
      "It is not a sexually transmitted infection",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Twitching motility is seen on wet saline mount (Option B)**\n\nüî¨ **TRICHOMONAS VAGINALIS:**\n\n**ORGANISM:**\n‚Ä¢ **Flagellated protozoan** (5 flagella: 4 anterior + 1 posterior) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Sexually transmitted infection (STI)** ‚≠ê\n‚Ä¢ **No cyst stage** (only trophozoite form) ‚≠ê\n\n**MORPHOLOGY:**\n‚Ä¢ **Pear-shaped** trophozoite\n‚Ä¢ **Size:** 10-20 Œºm\n‚Ä¢ **5 flagella** + **Undulating membrane**\n‚Ä¢ **Single nucleus**\n\n**CHARACTERISTIC MOTILITY:**\n‚Ä¢ **\"Jerky\"/\"Twitching\" motility** ‚≠ê‚≠ê‚≠ê **(DIAGNOSTIC)**\n‚Ä¢ Due to flagellar beating + undulating membrane\n‚Ä¢ **Actively motile** in fresh warm saline mount\n\n**DIAGNOSIS:**\n\n**Wet saline mount** ‚≠ê‚≠ê‚≠ê **(GOLD STANDARD - POINT-OF-CARE)**:\n‚Ä¢ **Motile trophozoites** with jerky movement\n‚Ä¢ Best seen in **fresh** specimen (<30 min)\n‚Ä¢ **Warm** saline (room temperature)\n‚Ä¢ **Sensitivity:** 60-70%\n\n**Other methods:**\n‚Ä¢ **Culture:** Diamond's medium (most sensitive, 95%)\n‚Ä¢ **Pap smear:** Can detect (50% sensitive)\n‚Ä¢ **NAAT (PCR):** High sensitivity\n‚Ä¢ **pH:** Vaginal pH >4.5 ‚≠ê\n\n**CLINICAL:**\n‚Ä¢ **\"Strawberry cervix\"** (punctate hemorrhages) ‚≠ê\n‚Ä¢ **Frothy, yellow-green discharge** ‚≠ê\n‚Ä¢ **Vulvovaginal irritation**\n‚Ä¢ **Dysuria, dyspareunia**\n‚Ä¢ **Foul-smelling discharge**\n\n**TREATMENT:**\n‚Ä¢ **Metronidazole** 2g single dose ‚≠ê‚≠ê‚≠ê (or 500mg BD √ó 7 days)\n‚Ä¢ **Tinidazole** 2g single dose (alternative)\n‚Ä¢ **Treat sexual partner** (prevent reinfection)\n‚Ä¢ **Avoid alcohol** (disulfiram-like reaction)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**\"It cannot be cultured\"** ‚ùå:\n‚Ä¢ **FALSE** - Can be cultured in **Diamond's medium**\n‚Ä¢ Culture is actually **most sensitive** test (95%)\n\n**\"Cysts are seen\"** ‚ùå:\n‚Ä¢ **FALSE** - Trichomonas has **NO CYST STAGE** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Only trophozoite** form exists\n‚Ä¢ This is a key differentiating feature from other protozoa (Giardia, Entamoeba have cysts)\n\n**\"It is not an STI\"** ‚ùå:\n‚Ä¢ **FALSE** - It **IS** a **sexually transmitted infection** ‚≠ê\n‚Ä¢ Most common **non-viral STI**\n\nüí° **KEY:** **Twitching/jerky motility on wet mount = Trichomonas vaginalis** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-3",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "A lady from West Rajasthan presented with an ulcer surrounded by erythema on the right leg. d Microscopy of the biopsy from the edge of the ulcer showed organisms with dark staining nuclei and kinetoplast. What is the most likely causative agent?",
    options: [
      "Leishmania tropica",
      "Babesia a",
      "Trypanosoma",
      "Histoplasma",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Leishmania tropica (Option A)**\n\nüî¨ **CUTANEOUS LEISHMANIASIS:**\n\n**ETIOLOGY:**\n‚Ä¢ **Leishmania tropica** ‚≠ê‚≠ê‚≠ê (Old World cutaneous leishmaniasis)\n‚Ä¢ **Vector:** **Sandfly** (*Phlebotomus*) ‚≠ê\n‚Ä¢ **Endemic:** West Rajasthan, Middle East, North Africa\n\n**CLINICAL PRESENTATION:**\n‚Ä¢ **Painless ulcer** on exposed skin (face, limbs) ‚≠ê\n‚Ä¢ **Surrounded by erythema/induration**\n‚Ä¢ **\"Volcano sign\"** - raised margins, central ulceration\n‚Ä¢ **Chronic, non-healing** (months)\n\n**DIAGNOSTIC FEATURE IN THIS CASE:**\n\n**Microscopy showing:**\n‚Ä¢ **Dark-staining nuclei** ‚≠ê\n‚Ä¢ **Kinetoplast** (bar-shaped structure) ‚≠ê‚≠ê‚≠ê **(PATHOGNOMONIC)**\n\n**LEISHMANIA AMASTIGOTE STRUCTURE:**\n‚Ä¢ **Oval/round** intracellular form (2-4 Œºm)\n‚Ä¢ **Nucleus** (large, round, dark-staining)\n‚Ä¢ **Kinetoplast** (rod-shaped, perpendicular to nucleus) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Found in macrophages** (\"Donovan bodies\")\n‚Ä¢ **No flagella** (amastigote = without flagella)\n\n**FORMS OF LEISHMANIA:**\n\n**Amastigote** (in human/mammal):\n‚Ä¢ **Intracellular** (in macrophages)\n‚Ä¢ **Nucleus + Kinetoplast**\n‚Ä¢ **Non-motile**\n\n**Promastigote** (in sandfly):\n‚Ä¢ **Extracellular**\n‚Ä¢ **Flagellated** (motile)\n‚Ä¢ Develops in sandfly gut\n\n**TYPES OF LEISHMANIASIS:**\n\n**1. Cutaneous (CL):**\n‚Ä¢ **L. tropica, L. major** (Old World)\n‚Ä¢ **L. braziliensis** (New World)\n‚Ä¢ **Skin ulcers**\n\n**2. Mucocutaneous (MCL):**\n‚Ä¢ **L. braziliensis** (\"Espundia\")\n‚Ä¢ Destroys nasal/oral mucosa\n\n**3. Visceral (Kala-azar):**\n‚Ä¢ **L. donovani** ‚≠ê\n‚Ä¢ Fever, hepatosplenomegaly, pancytopenia\n\n**DIAGNOSIS:**\n‚Ä¢ **Slit-skin smear** from edge of ulcer ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Giemsa staining** ‚Üí Amastigotes in macrophages\n‚Ä¢ **Culture:** NNN medium (Novy-MacNeal-Nicolle)\n‚Ä¢ **rK39 antigen** (for visceral)\n\n**TREATMENT:**\n‚Ä¢ **Sodium stibogluconate** (pentavalent antimony) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Amphotericin B** (severe cases)\n‚Ä¢ **Miltefosine** (oral, for VL)\n‚Ä¢ **Cryotherapy** (small CL lesions)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Babesia** ‚ùå:\n‚Ä¢ **Intraerythrocytic** parasite\n‚Ä¢ **Ring forms** in RBCs (\"Maltese cross\")\n‚Ä¢ No kinetoplast\n\n**Trypanosoma** ‚ùå:\n‚Ä¢ **Extracellular** in blood\n‚Ä¢ **Trypomastigote** with **posterior kinetoplast**\n‚Ä¢ **Undulating membrane**\n\n**Histoplasma** ‚ùå:\n‚Ä¢ **Fungus** (not protozoa)\n‚Ä¢ **Intracellular yeast** in macrophages\n‚Ä¢ **No kinetoplast** (budding yeast forms)\n\nüí° **KEY:** **Nucleus + Kinetoplast in macrophages = Leishmania amastigote** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-4",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "r A child presents with a fever and a rash. Urine examination showed cells with owl's eye aPppearance. What is the most likely diagnosis?",
    options: [
      "C ytomegalovirus",
      "Epstein-Barr virus",
      "Herpes simplex virus",
      "Toxoplasma gondii",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Cytomegalovirus (Option A)**\n\nüî¨ **CYTOMEGALOVIRUS (CMV):**\n\n**ORGANISM:**\n‚Ä¢ **Cytomegalovirus** - **Herpesviridae family** (HHV-5) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **DNA virus**\n‚Ä¢ **Largest herpesvirus**\n‚Ä¢ **Latent infection** in monocytes/lymphocytes\n\n**PATHOGNOMONIC FINDING:**\n\n**\"OWL'S EYE\" CELLS** ‚≠ê‚≠ê‚≠ê **(DIAGNOSTIC)**:\n‚Ä¢ **Large cells** (cytomegaly = enlarged cells)\n‚Ä¢ **Large nuclear inclusion** (eosinophilic, central)\n‚Ä¢ **Clear halo** around inclusion (\"owl's eye\" appearance)\n‚Ä¢ **Basophilic cytoplasmic inclusions** (smaller)\n‚Ä¢ Found in **urine, lung, brain, liver** specimens\n\n**CLINICAL PRESENTATIONS:**\n\n**1. CONGENITAL CMV** ‚≠ê:\n‚Ä¢ **TORCH infection**\n‚Ä¢ **Blueberry muffin rash**\n‚Ä¢ **Microcephaly**, **periventricular calcifications**\n‚Ä¢ **Hearing loss** (most common sequela)\n‚Ä¢ **Hepatosplenomegaly**, **jaundice**\n‚Ä¢ **Chorioretinitis**\n\n**2. MONONUCLEOSIS SYNDROME:**\n‚Ä¢ **Heterophile-negative** mono\n‚Ä¢ Fever, lymphadenopathy, hepatitis\n‚Ä¢ Unlike EBV: **No pharyngitis**\n\n**3. IMMUNOCOMPROMISED (HIV, Transplant):**\n‚Ä¢ **CMV retinitis** ‚Üí Blindness ‚≠ê\n‚Ä¢ **CMV colitis** ‚Üí Bloody diarrhea\n‚Ä¢ **CMV pneumonitis**\n‚Ä¢ **CMV encephalitis**\n\n**DIAGNOSIS:**\n\n**Histopathology** ‚≠ê‚≠ê‚≠ê **(GOLD STANDARD)**:\n‚Ä¢ **Owl's eye inclusions**\n\n**Urine analysis** ‚≠ê:\n‚Ä¢ **Cytology:** Owl's eye cells in shed renal tubular cells\n‚Ä¢ **Viral culture** from urine\n‚Ä¢ **CMV pp65 antigenemia**\n\n**Serology:**\n‚Ä¢ **IgM anti-CMV** (acute infection)\n‚Ä¢ **IgG anti-CMV** (past infection, 50-90% seropositive)\n\n**PCR:**\n‚Ä¢ **Quantitative CMV DNA** (viral load monitoring)\n\n**TREATMENT:**\n\n**1st line:** **Ganciclovir** (IV) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Or **Valganciclovir** (oral prodrug)\n\n**2nd line:**\n‚Ä¢ **Foscarnet** (if ganciclovir-resistant)\n‚Ä¢ **Cidofovir**\n\n**Prophylaxis:**\n‚Ä¢ **Valganciclovir** (transplant recipients)\n‚Ä¢ **Ganciclovir** (HIV with CD4 <50)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Epstein-Barr virus** ‚ùå:\n‚Ä¢ **Atypical lymphocytes** (Downey cells) on blood smear\n‚Ä¢ **Heterophile-positive** mono (Monospot test)\n‚Ä¢ **No owl's eye inclusions**\n\n**Herpes simplex virus** ‚ùå:\n‚Ä¢ **Cowdry type A inclusions** (eosinophilic, intranuclear)\n‚Ä¢ **Multinucleated giant cells** (Tzanck smear)\n‚Ä¢ **Vesicular lesions**\n‚Ä¢ No owl's eye appearance\n\n**Toxoplasma gondii** ‚ùå:\n‚Ä¢ **Protozoan** (not virus)\n‚Ä¢ **Tachyzoites/bradyzoites** on microscopy\n‚Ä¢ **Ring-enhancing lesions** on brain CT\n‚Ä¢ No nuclear inclusions\n\nüí° **KEY:** **Owl's eye inclusions in urine = CMV** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-5",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "Infection with Clonorchis sinensis is associated with an increased risk of__?",
    options: [
      "Cervical cancer",
      "Cholangiocarcinoma",
      "Gastric carcinom e",
      "Bladder carcinoma",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Cholangiocarcinoma (Option B)**\n\nüî¨ **CLONORCHIS SINENSIS (Chinese Liver Fluke):**\n\n**ORGANISM:**\n‚Ä¢ **Trematode** (fluke) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Endemic:** East Asia (China, Korea, Vietnam)\n‚Ä¢ **Definitive host:** Humans, dogs, cats\n\n**LIFE CYCLE:**\n‚Ä¢ **Eggs** in feces ‚Üí Water ‚Üí **Snail** (1st intermediate host)\n‚Ä¢ Cercaria ‚Üí **Freshwater fish** (2nd intermediate host)\n‚Ä¢ **Human ingestion** of **raw/undercooked fish** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Metacercaria ‚Üí **Bile ducts** (adult fluke)\n\n**LOCATION:**\n‚Ä¢ **Intrahepatic and extrahepatic bile ducts** ‚≠ê\n‚Ä¢ Adults live **10-25 years**\n\n**PATHOGENESIS:**\n\n**Mechanical irritation** + **Chronic inflammation**:\n‚Ä¢ **Chronic cholangitis**\n‚Ä¢ **Periductal fibrosis**\n‚Ä¢ **Bile duct proliferation/hyperplasia**\n‚Ä¢ **Adenomatous hyperplasia**\n‚Ä¢ ‚Üí **Cholangiocarcinoma** ‚≠ê‚≠ê‚≠ê\n\n**CARCINOGENIC MECHANISM:**\n‚Ä¢ **Chronic inflammation** (decades)\n‚Ä¢ **Mechanical irritation** from fluke\n‚Ä¢ **Metabolites/excretory products** ‚Üí DNA damage\n‚Ä¢ **Nitrosamines** production\n‚Ä¢ ‚Üí **Malignant transformation**\n\n**ASSOCIATED MALIGNANCY:**\n\n**CHOLANGIOCARCINOMA (Bile Duct Cancer)** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ **Risk increased 15-fold** in infected individuals\n‚Ä¢ **Endemic areas:** Very high CCA rates\n‚Ä¢ **Thailand:** Highest CCA incidence (due to *Opisthorchis viverrini*, similar fluke)\n\n**CLINICAL:**\n‚Ä¢ **Asymptomatic** (majority)\n‚Ä¢ **Recurrent cholangitis**\n‚Ä¢ **Biliary colic**\n‚Ä¢ **Jaundice, hepatomegaly**\n‚Ä¢ **Pancreatitis** (if pancreatic duct involved)\n\n**DIAGNOSIS:**\n‚Ä¢ **Stool microscopy:** **Operculated eggs** (flask-shaped) ‚≠ê\n‚Ä¢ **Bile/duodenal aspirate:** Eggs\n‚Ä¢ **ERCP:** Adult flukes in bile ducts\n‚Ä¢ **Imaging:** Bile duct dilatation, stones\n\n**TREATMENT:**\n‚Ä¢ **Praziquantel** 25 mg/kg TDS √ó 2 days ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Albendazole** (alternative)\n\n**OTHER PARASITE-CANCER ASSOCIATIONS:**\n\n**Schistosoma haematobium** ‚Üí **Bladder carcinoma** ‚≠ê:\n‚Ä¢ Chronic cystitis ‚Üí Squamous cell carcinoma\n\n**Opisthorchis viverrini** ‚Üí **Cholangiocarcinoma**:\n‚Ä¢ Similar to Clonorchis (SE Asia)\n\n**H. pylori** ‚Üí **Gastric carcinoma**, **MALT lymphoma**\n\n**EBV** ‚Üí **Nasopharyngeal carcinoma**, **Burkitt's lymphoma**\n\n**HPV 16/18** ‚Üí **Cervical cancer**\n\nüí° **KEY:** **Clonorchis sinensis ‚Üí Chronic cholangitis ‚Üí Cholangiocarcinoma** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-6",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "a A patient presented with complaints of persistent cough and weight loss. He had a history of contact with multiple sexual partners. He was diagnosed as HIV positive 6 months back and is poorly adherent to his medicationLs. The fungal culture of sputum was negative. On Gomori methamine silver staining, the cells showed darkly stained crescent-shaped cysts. What is the most likely causative organism?",
    options: [
      "Paracoccidiodes brasiliensis",
      "Histoplasma capsulatum",
      "Coccidiodes immitis r",
      "PPneumocystis jerovecii",
    ],
    correctAnswer: 3,
    explanation: "‚úÖ ANSWER: **Pneumocystis jirovecii (Option D)**\n\nüî¨ **PNEUMOCYSTIS JIROVECII PNEUMONIA (PCP):**\n\n**ORGANISM:**\n‚Ä¢ **Pneumocystis jirovecii** (formerly *P. carinii*) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Fungus** (previously classified as protozoan)\n‚Ä¢ **Opportunistic pathogen**\n‚Ä¢ **Airborne transmission**\n\n**RISK FACTORS:**\n‚Ä¢ **HIV/AIDS** (CD4 <200/mm¬≥) ‚≠ê‚≠ê‚≠ê **(MOST COMMON)**\n‚Ä¢ **Immunosuppression:** Transplant, cancer chemotherapy\n‚Ä¢ **Chronic corticosteroids**\n‚Ä¢ **Poor ART adherence** ‚≠ê (as in this case)\n\n**CLINICAL:**\n‚Ä¢ **Subacute onset** (weeks)\n‚Ä¢ **Persistent dry cough** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Progressive dyspnea** (exertional ‚Üí rest)\n‚Ä¢ **Fever**\n‚Ä¢ **Weight loss**\n‚Ä¢ **Hypoxemia** (low O‚ÇÇ saturation)\n\n**DIAGNOSTIC CLUE IN THIS CASE:**\n\n**Gomori methenamine silver (GMS) staining** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ Shows **darkly stained crescent-shaped/cup-shaped cysts** ‚≠ê‚≠ê‚≠ê **(PATHOGNOMONIC)**\n‚Ä¢ **\"Crushed ping-pong ball\" appearance**\n‚Ä¢ Cysts: 5-8 Œºm diameter\n\n**KEY POINT:** **Fungal culture negative** ‚≠ê\n‚Ä¢ **Pneumocystis cannot be cultured** on routine fungal media!\n‚Ä¢ Requires **special techniques** (rarely done)\n\n**OTHER DIAGNOSTIC METHODS:**\n\n**Microscopy:**\n‚Ä¢ **GMS stain:** Cyst walls (black/brown) ‚≠ê\n‚Ä¢ **Toluidine blue stain:** Cysts (blue-purple)\n‚Ä¢ **Giemsa/Wright stain:** Trophozoites (not cysts)\n\n**Specimen:**\n‚Ä¢ **Induced sputum** (sensitivity 50-90%)\n‚Ä¢ **Bronchoalveolar lavage (BAL)** ‚≠ê (>90% sensitive - gold standard)\n\n**Serology:**\n‚Ä¢ **Œ≤-D-glucan** (elevated) - non-specific\n‚Ä¢ **LDH elevated** (non-specific)\n\n**Imaging (CXR):**\n‚Ä¢ **Bilateral interstitial infiltrates** (\"ground-glass\" opacities) ‚≠ê\n‚Ä¢ **Perihilar** distribution\n‚Ä¢ **Pneumatoceles** (if severe)\n\n**TREATMENT:**\n\n**1st line:** **TMP-SMX** (Trimethoprim-Sulfamethoxazole) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **High-dose:** TMP 15-20 mg/kg/day √ó 21 days\n‚Ä¢ **+ Corticosteroids** if PaO‚ÇÇ <70 mmHg or A-a gradient >35\n\n**2nd line:**\n‚Ä¢ **Pentamidine** (IV)\n‚Ä¢ **Atovaquone** (oral, mild disease)\n‚Ä¢ **Clindamycin + Primaquine**\n\n**PROPHYLAXIS:**\n‚Ä¢ **Indication:** HIV with **CD4 <200/mm¬≥** ‚≠ê\n‚Ä¢ **Drug:** TMP-SMX DS (1 tab daily or 3x/week)\n‚Ä¢ **Alternative:** Dapsone, atovaquone, pentamidine inhaled\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Paracoccidioides brasiliensis** ‚ùå:\n‚Ä¢ **\"Pilot wheel\" appearance** (multiple buds)\n‚Ä¢ Culture positive (Sabouraud agar)\n‚Ä¢ Endemic to South America\n\n**Histoplasma capsulatum** ‚ùå:\n‚Ä¢ **Small intracellular yeasts** (2-4 Œºm)\n‚Ä¢ **Within macrophages**\n‚Ä¢ Culture positive\n‚Ä¢ No crescent-shaped cysts\n\n**Coccidioides immitis** ‚ùå:\n‚Ä¢ **Spherules** with endospores\n‚Ä¢ Culture positive\n‚Ä¢ Endemic to SW USA\n\nüí° **KEY:** **HIV + Dry cough + GMS crescent cysts + Culture negative = PCP** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-7",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "A sewage worker presented with abdominal pain, jaundice, conjunctival injection, and blood in the urine for the past 5 days. Which of the following is the investigation of choice?",
    options: [
      "Widal test",
      "Microscopic agglutination test",
      "Weil-Felix reaction",
      "Paul-Bunnell test",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Microscopic agglutination test (Option B)**\n\nüî¨ **LEPTOSPIROSIS (Weil's Disease):**\n\n**ORGANISM:**\n‚Ä¢ **Leptospira interrogans** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Spirochete** (spiral bacteria)\n‚Ä¢ **Zoonotic** infection\n\n**EPIDEMIOLOGY:**\n‚Ä¢ **Occupational risk:** Sewage workers, farmers, veterinarians ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Reservoir:** Rats, dogs, cattle (urine)\n‚Ä¢ **Transmission:** Contact with contaminated water/soil\n‚Ä¢ **Portal of entry:** Skin abrasions, mucous membranes\n\n**CLINICAL PRESENTATION (THIS CASE):**\n\n**WEIL'S DISEASE** (Severe leptospirosis) ‚≠ê‚≠ê‚≠ê:\n\n**Classic triad:**\n1. **Jaundice** ‚≠ê (hepatic involvement)\n2. **Renal failure** (hematuria) ‚≠ê\n3. **Hemorrhagic manifestations** (pulmonary, GI bleeding)\n\n**Additional features:**\n‚Ä¢ **Conjunctival suffusion/injection** ‚≠ê‚≠ê‚≠ê **(CHARACTERISTIC)**\n  - Redness without discharge (non-purulent)\n‚Ä¢ **Abdominal pain**\n‚Ä¢ **Fever** (biphasic)\n‚Ä¢ **Myalgia** (calf muscles)\n‚Ä¢ **Headache**\n\n**PHASES:**\n\n**Phase 1 (Septicemic):** Days 1-7\n‚Ä¢ High fever, myalgia, conjunctival suffusion\n‚Ä¢ Leptospires in blood/CSF\n\n**Phase 2 (Immune):** Days 7-30\n‚Ä¢ Antibodies appear\n‚Ä¢ Organ involvement (liver, kidney, meninges)\n‚Ä¢ Leptospires in urine\n\n**DIAGNOSIS:**\n\n**MICROSCOPIC AGGLUTINATION TEST (MAT)** ‚≠ê‚≠ê‚≠ê **(GOLD STANDARD)**:\n‚Ä¢ **Serovar-specific**\n‚Ä¢ **Live leptospires** + Patient serum\n‚Ä¢ **Positive:** ‚â•1:400 titer (single) or **4-fold rise** (paired)\n‚Ä¢ **Most sensitive and specific**\n‚Ä¢ **Reference standard** for leptospirosis\n\n**Other tests:**\n‚Ä¢ **ELISA** (IgM) - rapid, early diagnosis\n‚Ä¢ **Dark-field microscopy** (blood/urine) - see spirochetes\n‚Ä¢ **Culture:** Fletcher's/EMJH medium (slow, 4-6 weeks)\n‚Ä¢ **PCR** (blood, urine)\n\n**Lab findings:**\n‚Ä¢ **Elevated bilirubin** (conjugated > unconjugated)\n‚Ä¢ **Thrombocytopenia**\n‚Ä¢ **Elevated creatinine** (renal failure)\n‚Ä¢ **Elevated CPK** (myositis)\n\n**TREATMENT:**\n\n**Mild:** **Doxycycline** 100mg BD √ó 7 days ‚≠ê\n\n**Severe (Weil's):** **Penicillin G** or **Ceftriaxone** IV ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Supportive:** Dialysis (if renal failure)\n\n**Prophylaxis:**\n‚Ä¢ **Doxycycline** 200mg weekly (high-risk exposure)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Widal test** ‚ùå:\n‚Ä¢ For **Typhoid fever** (Salmonella typhi)\n‚Ä¢ Tests for O and H antigens\n\n**Weil-Felix reaction** ‚ùå:\n‚Ä¢ For **Rickettsial infections** (scrub typhus, epidemic typhus)\n‚Ä¢ Based on cross-reactivity with Proteus antigens\n\n**Paul-Bunnell test** ‚ùå:\n‚Ä¢ For **Infectious mononucleosis** (EBV)\n‚Ä¢ Detects **heterophile antibodies**\n\nüí° **KEY:** **Sewage worker + Jaundice + Conjunctival suffusion + Hematuria = Leptospirosis ‚Üí MAT** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-8",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "e Which of the following laboratory test is used to diagnose rotavirus diarrhea?",
    options: [
      "Antigen detection in the stool sample",
      "Antigen detection in blood d",
      "Antibody detection in serum",
      "Light microscopy of stool specimen",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Antigen detection in the stool sample (Option A)**\n\nüî¨ **ROTAVIRUS DIARRHEA:**\n\n**ORGANISM:**\n‚Ä¢ **Rotavirus** - **Reoviridae family** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **dsRNA virus** (double-stranded RNA)\n‚Ä¢ **Wheel-shaped** (rota = wheel)\n‚Ä¢ **11 segments** of RNA\n\n**EPIDEMIOLOGY:**\n‚Ä¢ **Most common cause** of severe diarrhea in **children <5 years** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Peak age:** 6-24 months\n‚Ä¢ **Fecal-oral transmission**\n‚Ä¢ **Winter** seasonality (temperate climates)\n\n**CLINICAL:**\n‚Ä¢ **Watery diarrhea** (non-bloody) ‚≠ê\n‚Ä¢ **Vomiting** (prominent) ‚≠ê\n‚Ä¢ **Fever**\n‚Ä¢ **Severe dehydration** (life-threatening)\n‚Ä¢ **Incubation:** 1-3 days\n‚Ä¢ **Duration:** 5-7 days\n\n**DIAGNOSIS:**\n\n**ANTIGEN DETECTION IN STOOL** ‚≠ê‚≠ê‚≠ê **(GOLD STANDARD - POINT-OF-CARE)**:\n\n**Methods:**\n\n**1. ELISA** (most common):\n‚Ä¢ Detects **rotavirus antigens** (VP6 capsid protein)\n‚Ä¢ **Rapid** (15-30 min)\n‚Ä¢ **High sensitivity** (90-95%)\n‚Ä¢ **High specificity** (>95%)\n\n**2. Latex agglutination:**\n‚Ä¢ Detects viral antigens\n‚Ä¢ Rapid, bedside test\n\n**3. Immunochromatography (ICT):**\n‚Ä¢ Rapid cassette test\n‚Ä¢ Point-of-care\n\n**Other methods:**\n‚Ä¢ **Electron microscopy:** See wheel-shaped virions (research)\n‚Ä¢ **RT-PCR:** Molecular detection (most sensitive)\n‚Ä¢ **Viral culture:** Not routinely done (difficult)\n\n**WHY STOOL SAMPLE:**\n‚Ä¢ **Virus shed in feces** (high concentrations) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Peak shedding during acute diarrhea\n‚Ä¢ **NOT in blood** (localized GI infection)\n\n**PATHOGENESIS:**\n‚Ä¢ Infects **villous epithelial cells** of **small intestine** ‚≠ê\n‚Ä¢ **Villous atrophy** ‚Üí ‚Üì absorption\n‚Ä¢ **NSP4 enterotoxin** ‚Üí ‚Üë secretion\n‚Ä¢ ‚Üí **Osmotic + secretory diarrhea**\n\n**MANAGEMENT:**\n‚Ä¢ **Oral rehydration solution (ORS)** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Zinc supplementation** (10-20mg/day √ó 10-14 days)\n‚Ä¢ **Continue feeding** (not contraindicated)\n‚Ä¢ **No antibiotics** (viral)\n\n**PREVENTION:**\n\n**VACCINES** ‚≠ê‚≠ê‚≠ê:\n\n**1. Rotarix** (GlaxoSmithKline):\n‚Ä¢ **Live attenuated**\n‚Ä¢ **2 doses** (6 and 10 weeks)\n\n**2. RotaTeq** (Merck):\n‚Ä¢ **Live attenuated pentavalent**\n‚Ä¢ **3 doses** (6, 10, and 14 weeks)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Antigen detection in blood** ‚ùå:\n‚Ä¢ **FALSE** - Rotavirus causes **localized GI infection**\n‚Ä¢ **NOT viremic** (doesn't enter blood)\n‚Ä¢ Stool is the diagnostic sample\n\n**Antibody detection in serum** ‚ùå:\n‚Ä¢ Detects **past exposure** (IgG) or **recent infection** (IgM)\n‚Ä¢ **NOT useful for acute diagnosis** (takes days to develop)\n‚Ä¢ Most adults have antibodies (prior exposure)\n\n**Light microscopy of stool** ‚ùå:\n‚Ä¢ **Cannot see** rotavirus by light microscopy\n‚Ä¢ Virus too small (70nm)\n‚Ä¢ Requires **electron microscopy**\n‚Ä¢ No specific cells/organisms visible\n\nüí° **KEY:** **Rotavirus diagnosis = Stool antigen ELISA (rapid, point-of-care)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-9",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "e A boy presented with a fever and chills. Rapid test was positive for specific antigen HRP-2. Which of the following species of Plasmodium is the most likely causative agent?",
    options: [
      "Plasmodium falciparum OP2: Plasmodium malaria O3: Plasmodium vivax O4: Plasmodium ovale",
      "Option 2",
      "Plasmodium vivax",
      "Plasmodium ovale",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Plasmodium falciparum (Option A)**\n\nüî¨ **MALARIA - HRP-2 RAPID DIAGNOSTIC TEST:**\n\n**HRP-2 ANTIGEN:**\n‚Ä¢ **Histidine-Rich Protein 2** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Species-specific** for **Plasmodium falciparum** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Water-soluble protein** produced by asexual stages and young gametocytes\n‚Ä¢ **Persists** in blood for 2-4 weeks after parasite clearance\n\n**RAPID DIAGNOSTIC TESTS (RDTs):**\n\n**HRP-2 based** ‚≠ê‚≠ê‚≠ê **(MOST COMMON RDT)**:\n‚Ä¢ **Detects:** **P. falciparum** ONLY\n‚Ä¢ **Advantage:** High sensitivity, remains positive after treatment\n‚Ä¢ **Disadvantage:** Cannot detect other species, false positive (persistent HRP-2)\n\n**pLDH (Plasmodium Lactate Dehydrogenase):**\n‚Ä¢ **Pan-malarial** marker (all species)\n‚Ä¢ Or **species-specific** pLDH for P. vivax/P. falciparum\n‚Ä¢ Clears rapidly after treatment\n\n**COMBINATION RDTs:**\n‚Ä¢ **HRP-2 + pLDH (pan):** Detects P. falciparum + other species\n‚Ä¢ **HRP-2 + pLDH (Pv):** Differentiates P. falciparum vs P. vivax\n\n**PLASMODIUM FALCIPARUM:**\n\n**CHARACTERISTICS:**\n‚Ä¢ **Most virulent** species ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Highest mortality**\n‚Ä¢ **No relapse** (no hypnozoites in liver)\n\n**CLINICAL:**\n‚Ä¢ **Cerebral malaria** ‚≠ê\n‚Ä¢ **Severe anemia**\n‚Ä¢ **Acute renal failure** (blackwater fever)\n‚Ä¢ **ARDS**\n‚Ä¢ **Hypoglycemia**\n‚Ä¢ **Lactic acidosis**\n\n**PERIPHERAL SMEAR:**\n‚Ä¢ **Ring forms** (often multiple rings per RBC) ‚≠ê\n‚Ä¢ **Banana-shaped gametocytes** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **High parasitemia** (>5% ‚Üí severe)\n‚Ä¢ **All stages** in peripheral blood (NO schizont in uncomplicated)\n\n**TREATMENT:**\n\n**Uncomplicated:**\n‚Ä¢ **Artemisinin Combination Therapy (ACT)** ‚≠ê‚≠ê‚≠ê\n  - **Artesunate + SP** (Sulfadoxine-Pyrimethamine)\n  - **Artemether + Lumefantrine** (Coartem)\n\n**Severe:**\n‚Ä¢ **IV Artesunate** ‚≠ê‚≠ê‚≠ê (drug of choice)\n‚Ä¢ **IV Quinine** (alternative)\n\n**COMPARISON OF SPECIES:**\n\n| Feature | P. falciparum | P. vivax | P. ovale | P. malariae |\n|---------|--------------|----------|----------|-------------|\n| **HRP-2** | ‚úÖ Positive | ‚ùå Negative | ‚ùå Negative | ‚ùå Negative |\n| **Severity** | Severe | Moderate | Mild | Mild |\n| **Gametocyte** | Banana | Round | Round | Round |\n| **Relapse** | No | Yes | Yes | No |\n| **Cycle** | 48h | 48h | 48h | 72h |\n| **Ring forms** | Multiple | Single, large | Single, large | Single |\n\nüí° **KEY:** **HRP-2 positive = Plasmodium falciparum** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-10",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "A child was brought with complaints of high fever, multiple seizures, headache, and neck rigidity. CSF analysis showed low glucose, high protein, and many polymorphs. The CSF culture showed pleomorphic gram-negative bacilli. What is true about the causative organism?",
    options: [
      "It is bacitracin sensitive.",
      "Produces non-lactose fermenting colonies on MacConkey agar",
      "Exhibits satellitism around Staphylococcus aureus colonies r",
      "It exhibits alpha hemolysis on sheep blood agar",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Exhibits satellitism around Staphylococcus aureus colonies (Option C)**\n\nüî¨ **HAEMOPHILUS INFLUENZAE MENINGITIS:**\n\n**CLINICAL DIAGNOSIS:**\n‚Ä¢ **Child** with **meningitis** ‚≠ê\n‚Ä¢ **High fever, seizures, headache, neck rigidity**\n\n**CSF FINDINGS:**\n‚Ä¢ **Low glucose** (<40 mg/dL) ‚≠ê\n‚Ä¢ **High protein** (>45 mg/dL) ‚≠ê\n‚Ä¢ **Pleocytosis:** **Polymorphs dominant** ‚≠ê‚≠ê‚≠ê **(BACTERIAL MENINGITIS)**\n‚Ä¢ ‚Üí **Pyogenic meningitis**\n\n**CSF CULTURE:**\n‚Ä¢ **Pleomorphic gram-negative bacilli/coccobacilli** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ ‚Üí **Haemophilus influenzae** (most likely)\n\n**HAEMOPHILUS INFLUENZAE:**\n\n**ORGANISM:**\n‚Ä¢ **Gram-negative coccobacillus** (pleomorphic) ‚≠ê\n‚Ä¢ **Fastidious** (requires special growth factors)\n‚Ä¢ **Type b (Hib):** Most virulent, polysaccharide capsule\n\n**GROWTH REQUIREMENTS:**\n\n**\"X and V factors\"** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ **Factor X:** **Hemin** (hematin) - from RBCs\n‚Ä¢ **Factor V:** **NAD** (nicotinamide adenine dinucleotide)\n\n**SATELLITISM PHENOMENON** ‚≠ê‚≠ê‚≠ê **(DIAGNOSTIC)**:\n‚Ä¢ **Definition:** Enhanced growth of *H. influenzae* around **S. aureus** colonies\n‚Ä¢ **Mechanism:**\n  - **S. aureus produces NAD** (Factor V) ‚≠ê\n  - **S. aureus lyses RBCs** ‚Üí Releases hemin (Factor X)\n  - ‚Üí *H. influenzae* grows better near S. aureus\n‚Ä¢ **Test:** Streak *H. influenzae* + S. aureus on **blood agar** ‚Üí Satellite colonies appear around staph\n\n**CULTURE MEDIA:**\n‚Ä¢ **Chocolate agar** ‚≠ê‚≠ê‚≠ê (heated blood - releases X & V)\n‚Ä¢ **Blood agar + X & V factor discs**\n‚Ä¢ **NO growth** on MacConkey (gram-negative, but fastidious)\n\n**CLINICAL:**\n‚Ä¢ **Meningitis** (children <5 years, pre-Hib vaccine era) ‚≠ê\n‚Ä¢ **Epiglottitis** (\"cherry-red\" epiglottis)\n‚Ä¢ **Pneumonia**\n‚Ä¢ **Otitis media**\n\n**TREATMENT:**\n‚Ä¢ **Ceftriaxone** or **Cefotaxime** ‚≠ê‚≠ê‚≠ê (3rd gen cephalosporin)\n‚Ä¢ Avoid ampicillin (30-40% resistance due to Œ≤-lactamase)\n\n**PREVENTION:**\n‚Ä¢ **Hib vaccine** (PRP-T conjugate) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Part of routine immunization\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Bacitracin sensitive** ‚ùå:\n‚Ä¢ **Group A Streptococcus** (S. pyogenes) is bacitracin sensitive\n‚Ä¢ *H. influenzae* is **gram-negative** (bacitracin tests gram-positive cocci)\n\n**Non-lactose fermenting on MacConkey** ‚ùå:\n‚Ä¢ *H. influenzae* **does NOT grow** on MacConkey agar ‚≠ê\n‚Ä¢ MacConkey is for **non-fastidious** gram-negative bacilli\n‚Ä¢ Only organisms like E. coli, Shigella, Salmonella grow on MacConkey\n\n**Alpha hemolysis on blood agar** ‚ùå:\n‚Ä¢ *H. influenzae* shows **NO hemolysis** on blood agar\n‚Ä¢ **Alpha hemolysis:** Streptococcus pneumoniae, viridans streptococci\n‚Ä¢ *H. influenzae* grown on blood agar (if X & V added) but no hemolysis\n\nüí° **KEY:** **Pleomorphic GNB + Satellitism around S. aureus = H. influenzae** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-11",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "A man presents with a history of dysuria aand urethral discharge after having unprotected sexual intercourse. Gram-staining of the purulent discharge is seen in the following image. What is the treatment of choice for this infection? L p e r P",
    options: [
      "Erythromycin",
      "Azithromycin",
      "Ceftriaxone",
      "Penicillin G",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Ceftriaxone (Option C)**\n\nüî¨ **GONOCOCCAL URETHRITIS:**\n\n**CLINICAL DIAGNOSIS:**\n‚Ä¢ **Dysuria** + **Purulent urethral discharge** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **History of unprotected sexual intercourse**\n‚Ä¢ **Male patient**\n\n**CAUSATIVE ORGANISM:**\n‚Ä¢ **Neisseria gonorrhoeae** ‚≠ê‚≠ê‚≠ê\n\n**GRAM STAIN FINDINGS:**\n‚Ä¢ **Gram-negative diplococci** ‚≠ê‚≠ê‚≠ê **(DIAGNOSTIC)**\n‚Ä¢ **Intracellular** (within polymorphonuclear leukocytes/PMNs) ‚≠ê\n‚Ä¢ **\"Kidney bean\" shape** (coffee bean, opposing concave sides)\n‚Ä¢ **In pairs** (diplococci)\n\n**SEXUALLY TRANSMITTED INFECTION:**\n‚Ä¢ **Most common bacterial STI** (after Chlamydia)\n‚Ä¢ **Incubation:** 2-7 days\n\n**CLINICAL MANIFESTATIONS:**\n\n**Men:**\n‚Ä¢ **Urethritis** ‚≠ê (90% symptomatic)\n  - Purulent discharge (thick, yellow-green)\n  - Dysuria\n‚Ä¢ **Epididymitis**, **prostatitis** (complications)\n\n**Women:**\n‚Ä¢ **Cervicitis** (50% asymptomatic)\n‚Ä¢ **PID** (pelvic inflammatory disease) ‚≠ê\n‚Ä¢ **Infertility**, **ectopic pregnancy**\n\n**Disseminated:**\n‚Ä¢ **Disseminated gonococcal infection (DGI)** (1-3%)\n‚Ä¢ **Arthritis-dermatitis syndrome** ‚≠ê\n  - Migratory polyarthritis\n  - Tenosynovitis\n  - Pustular skin lesions\n\n**Neonatal:**\n‚Ä¢ **Ophthalmia neonatorum** (purulent conjunctivitis)\n‚Ä¢ **Prophylaxis:** Erythromycin eye ointment at birth\n\n**TREATMENT:**\n\n**CURRENT RECOMMENDED TREATMENT** ‚≠ê‚≠ê‚≠ê:\n\n**Uncomplicated urethritis/cervicitis:**\n‚Ä¢ **Ceftriaxone 500mg IM single dose** ‚≠ê‚≠ê‚≠ê **(FIRST-LINE)**\n  - Or **1g IM** if weight >150 kg\n\n**+ Treat for Chlamydia** (often co-infected) ‚≠ê:\n‚Ä¢ **Azithromycin 1g PO single dose**\n‚Ä¢ Or **Doxycycline 100mg PO BD √ó 7 days**\n\n**WHY CEFTRIAXONE:**\n‚Ä¢ **Increasing resistance** to penicillin, fluoroquinolones, azithromycin ‚≠ê\n‚Ä¢ **3rd generation cephalosporin** remains effective\n‚Ä¢ **Single-dose IM** ‚Üí High compliance\n\n**Disseminated/Severe:**\n‚Ä¢ **Ceftriaxone 1-2g IV daily**\n\n**Ophthalmia neonatorum:**\n‚Ä¢ **Ceftriaxone 50mg/kg IM/IV** (single dose, max 125mg)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Erythromycin** ‚ùå:\n‚Ä¢ For **Chlamydia**, not Gonorrhea (as monotherapy)\n‚Ä¢ Not effective enough for N. gonorrhoeae\n\n**Azithromycin** ‚ùå:\n‚Ä¢ For **Chlamydia** ‚≠ê\n‚Ä¢ **Increasing resistance** in N. gonorrhoeae ‚≠ê\n‚Ä¢ **No longer recommended** as monotherapy for gonorrhea\n‚Ä¢ Can be used in combination with ceftriaxone for co-treatment\n\n**Penicillin G** ‚ùå:\n‚Ä¢ **High resistance** (>50% strains produce Œ≤-lactamase) ‚≠ê\n‚Ä¢ **No longer effective**\n‚Ä¢ Was first-line in the past\n\n**KEY RESISTANCE TRENDS:**\n‚Ä¢ **Penicillin:** High resistance (Œ≤-lactamase)\n‚Ä¢ **Fluoroquinolones:** High resistance (gyrase mutations)\n‚Ä¢ **Azithromycin:** Increasing resistance\n‚Ä¢ **Ceftriaxone:** Still effective (but monitor)\n\nüí° **KEY:** **Gonorrhea = GN diplococci in PMNs ‚Üí Ceftriaxone IM + Azithromycin (for Chlamydia)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-173",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "A patient presented with a high fever, altered sensorium, headache, neck rigidity, and seizures. He was diagnosed with HSV encephalitis. Which of the following tests can be used to confirm the diagnosis?",
    options: [
      "IgM in CSF",
      "Tzanck smear of CSF",
      "CSF PCR for viral DNA",
      "CSF culture on chick embryo lines",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **CSF PCR for viral DNA (Option C)**\n\nüî¨ **HSV ENCEPHALITIS DIAGNOSIS:**\n\n**THIS CASE:**\n‚Ä¢ **Fever**, **headache**, **neck rigidity** ‚≠ê\n‚Ä¢ **Altered sensorium**, **seizures** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Clinical diagnosis:** HSV encephalitis\n\n**GOLD STANDARD:** **CSF PCR for HSV DNA** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n\n**CSF PCR:**\n‚Ä¢ **Highly sensitive & specific** (>95%) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Detects viral DNA** directly\n‚Ä¢ **Rapid** (few hours)\n‚Ä¢ **Preferred diagnostic test** ‚≠ê‚≠ê‚≠ê\n\n**WHY NOT OTHERS:**\n\n‚Ä¢ **IgM in CSF:** Takes time to develop (7-10 days), LOW sensitivity early ‚≠ê\n‚Ä¢ **Tzanck smear:** For SKIN lesions (NOT CSF)\n‚Ä¢ **CSF culture:** SLOW (days-weeks), LOW sensitivity\n\n**CSF FINDINGS:**\n‚Ä¢ **Lymphocytic pleocytosis**\n‚Ä¢ **RBCs** (hemorrhagic)\n‚Ä¢ **Elevated protein**\n‚Ä¢ **Normal/low glucose**\n\n**IMAGING:**\n‚Ä¢ **MRI:** Bitemporal involvement ‚≠ê‚≠ê‚≠ê\n\n**TREATMENT:**\n‚Ä¢ **IV Acyclovir** (10 mg/kg q8h) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Start empirically** (don't wait for PCR)\n\nüí° **KEY:** **HSV encephalitis diagnosis = CSF PCR for HSV DNA** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-174",
    subjectId: "microbiology",
    chapterId: "neet-pg-2023",
    question: "e In a patient presented with a fever and a positive filarial antigen test, what is the next appropriate method of management? d",
    options: [
      "Bone marrow biopsy",
      "DEC provocation test",
      "Detection of microfilariae in the blood smaear",
      "Ultrasound of the scrotum",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Detection of microfilariae in blood smear (Option C)**\n\nüî¨ **FILARIASIS DIAGNOSIS:**\n\n**THIS CASE:**\n‚Ä¢ **Fever**\n‚Ä¢ **Positive filarial antigen test** ‚≠ê‚≠ê‚≠ê\n\n**FILARIAL ANTIGEN TEST:**\n‚Ä¢ **Detects circulating filarial antigen** (CFA)\n‚Ä¢ **Wuchereria bancrofti** specific ‚≠ê\n‚Ä¢ **ICT/ELISA**\n‚Ä¢ **High sensitivity & specificity**\n\n**NEXT STEP:** **Blood smear for microfilariae** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n\n**MICROFILARIAE DETECTION:**\n‚Ä¢ **Confirms active infection** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Specifies species**\n‚Ä¢ **Guides treatment**\n‚Ä¢ **Timing:** **Night blood** (10 PM - 2 AM) for W. bancrofti ‚≠ê‚≠ê‚≠ê (nocturnal periodicity)\n\n**TECHNIQUE:**\n‚Ä¢ **Thick blood smear** (concentrated)\n‚Ä¢ **Giemsa stain**\n\n**WHY NOT OTHERS:**\n\n‚Ä¢ **DEC provocation:** If blood smear negative (brings microfilariae to peripheral blood)\n‚Ä¢ **Bone marrow:** NOT indicated\n‚Ä¢ **Scrotal USS:** For filarial dance sign (BUT do blood smear first)\n\n**TREATMENT:**\n‚Ä¢ **DEC** (Diethylcarbamazine) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Albendazole**\n\nüí° **KEY:** **Positive antigen test ‚Üí Confirm with blood smear for microfilariae** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  }
];

export default questions;

// Helper function to get questions by chapter
export function getQuestionsByChapter(chapterId: string): Question[] {
  return questions.filter(q => q.chapterId === chapterId);
}

// Export question count
export const questionCount = questions.length;
